An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
Researchers report that people taking semaglutide kept eating fewer calories for more than a year. In plain terms: a study from Penn Medicine looked at how long the appetite-reducing effects of semaglutide last, and found the reduction in calorie intake persisted past twelve months. Semaglutide is the drug behind brand names you may have heard, like Ozempic and Wegovy. It is a synthetic copy of a natural gut hormone that tells your brain you’re full and slows how fast your stomach empties. Doctors use it to treat type 2 diabetes and, at higher doses, for weight management because it lowers appetite and helps people eat less. The study tracked people on semaglutide and measured how much they ate. Based on the report, the lowered calorie intake continued for over a year while participants were taking the medication. The write-up doesn’t give all the numbers here, so we can’t say exactly how big the calorie drop was or how many people were studied. We also don’t know whether the report came from a randomized trial, an observational study, or something else unless you read the full paper. This matters because many weight-loss strategies struggle to keep people eating less over time. If semaglutide reliably reduces appetite for a year or more, it could help people sustain weight loss or reduce weight regain. That’s relevant for people with obesity or metabolic disease, clinicians planning long-term treatment, and public-health planning about the role of medications in treating weight-related conditions. Important caveats: appetite suppression while on the drug is not the same as a cure. When people stop semaglutide, appetite and calorie intake often rebound, based on prior research. Semaglutide can cause side effects like nausea, vomiting, diarrhea, and rarely more serious issues; it’s a prescription medication and should be used under medical supervision. The snippet doesn’t say who was studied (age, health status), how large the effect was, or whether outcomes like weight, metabolic health, or quality of life were measured beyond calories, so there are limits to what this report proves. Bottom line: semaglutide appears to keep people eating fewer calories for over a year while they take it, which could support longer-term weight control, but details and long-term safety or what happens after stopping the drug still need full study and doctor guidance.
Source: Penn Medicine